Literature DB >> 28500659

Insulin sensitivity in relation to fat distribution and plasma adipocytokines among abusers of anabolic androgenic steroids.

Jon Jarløv Rasmussen1,2, Morten Schou2,3, Christian Selmer1, Marie Louise Johansen1,2, Finn Gustafsson2,4, Jan Frystyk5,6, Flemming Dela7,8, Jens Faber1,2, Caroline Kistorp1,2.   

Abstract

OBJECTIVE: Abuse of anabolic androgenic steroids (AAS) is prevalent among young men, but information regarding effects on insulin sensitivity and fat distribution is limited. The objective was to investigate insulin sensitivity in relation to fat distribution and adipocytokines among current and former AAS abusers compared with controls.
DESIGN: Cross-sectional study among men involved in recreational strength training. Current and former AAS abusers (n=37 and n=33) and controls (n=30) volunteered from the community.
METHODS: We assessed insulin sensitivity by Matsuda index (oral glucose tolerance test). Using overnight fasting blood samples, adiponectin and leptin were measured. Body composition and fat distribution, including visceral adipose tissue (VAT), were assessed by dual energy X-ray absorptiometry.
RESULTS: Current and former AAS abusers displayed lower Matsuda index than controls (%-difference (95%CI) from controls, -26% (-45; -1) and -39% (-55; -18)). Testosterone was markedly higher among current AAS abusers and subnormal among former AAS abusers compared with controls. Current AAS abusers displayed higher mean VAT than controls (388 (17) vs 293 (12) cm3 , P<.001) whereas body fat %, adiponectin and leptin concentrations were lower. In contrast, former AAS abusers showed highest leptin concentrations and body fat %. Multivariate linear regressions identified VAT as independent predictor of lower Matsuda index among current AAS abusers compared with controls; while body fat % independently predicted lower Matsuda index among former AAS abusers.
CONCLUSIONS: Both current and former AAS abusers displayed lower insulin sensitivity which could be mediated by higher VAT and total body fat %, respectively.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  adipokines; androgens; glucose intolerance; insulin resistance; intra-abdominal fat

Mesh:

Substances:

Year:  2017        PMID: 28500659     DOI: 10.1111/cen.13372

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  Could Overt Diabetes Be Triggered by Abuse of Selective Androgen Receptor Modulators and Growth Hormone Secretagogues? A Case Report and Review of the Literature.

Authors:  Richard Sotorník; Roguel Suissa; Jean-Luc Ardilouze
Journal:  Clin Diabetes       Date:  2022

2.  Discriminatory performance of adiponectin and leptin in the identification of impaired glucose tolerance: The Guangzhou Biobank Cohort Study - Cardiovascular Disease Subcohort.

Authors:  Konstantinos A Toulis; Chao Q Jiang; Karla Hemming; Krishnarajah Nirantharakumar; Kar K Cheng; Tai H Lam; G Neil Thomas
Journal:  PLoS One       Date:  2018-11-06       Impact factor: 3.240

3.  The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment.

Authors:  Ingrid Amalia Havnes; Marie Lindvik Jørstad; Jim McVeigh; Marie-Claire Van Hout; Astrid Bjørnebekk
Journal:  Subst Abuse       Date:  2020-02-18

4.  Anabolic Androgenic Steroid Abuse and their Health Impacts: A Cross-sectional Study among Body Builders in a City of Eastern India.

Authors:  Subraham Pany; Sandeep Kumar Panigrahi; E Venkata Rao; Lipilekha Patnaik; Trilochan Sahu
Journal:  Int J Prev Med       Date:  2019-10-09

Review 5.  How the love of muscle can break a heart: Impact of anabolic androgenic steroids on skeletal muscle hypertrophy, metabolic and cardiovascular health.

Authors:  Deaglan McCullough; Richard Webb; Kevin J Enright; Katie E Lane; Jim McVeigh; Claire E Stewart; Ian G Davies
Journal:  Rev Endocr Metab Disord       Date:  2020-12-02       Impact factor: 6.514

6.  Endogenous Testosterone Levels Are Associated with Risk of Type 2 Diabetes in Women without Established Comorbidity.

Authors:  Jon J Rasmussen; Christian Selmer; Signe Frøssing; Morten Schou; Jens Faber; Christian Torp-Pedersen; Gunnar H Gislason; Lars Køber; David M Hougaard; Arieh S Cohen; Caroline Kistorp
Journal:  J Endocr Soc       Date:  2020-05-05

Review 7.  Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective.

Authors:  Giovanni Corona; Giulia Rastrelli; Sara Marchiani; Sandra Filippi; Annamaria Morelli; Erica Sarchielli; Alessandra Sforza; Linda Vignozzi; Mario Maggi
Journal:  World J Mens Health       Date:  2021-06-01       Impact factor: 5.400

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.